Prevalence of low testosterone and predisposing risk factors in men with type 1 diabetes mellitus: Findings from the DCCT/EDIC

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 9, 2014, Pages E1655-E1660

  Holt, Sarah K ^a   Lopushnyan, Natalya ^a   Hotaling, James ^b   Sarma, Aruna V ^c   Dunn, Rodney L ^c   Cleary, Patricia A ^e   Braffett, Barbara H ^e   Gatcomb, Patricia ^f   Martin, Catherine ^d   Herman, William H ^d   Wessells, Hunter ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e GEORGE WASHINGTON UNIVERSITY   (United States)

^f YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; INSULIN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; AGE; AGED; ANDROGEN DEFICIENCY; ARTICLE; AUTONOMIC NEUROPATHY; BODY MASS; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ENZYME IMMUNOASSAY; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; OBESITY; PERIPHERAL NEUROPATHY; PREVALENCE; RISK FACTOR; TESTOSTERONE BLOOD LEVEL; ALGORITHM; BLOOD; DEFICIENCY; DIABETES MELLITUS, TYPE 1; ENDOCRINE SYSTEM DISEASES; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PERIPHERAL NERVOUS SYSTEM DISEASES;

ADULT; AGED; ALGORITHMS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; ENDOCRINE SYSTEM DISEASES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; PERIPHERAL NERVOUS SYSTEM DISEASES; PREVALENCE; RISK FACTORS; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE;

EID: 84907201100     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-1317     Document Type: Article

References (22)

1. Cooper AJ. Diagnosis and management of "endocrine impotence." Br Med J. 1972;2: 34-36.
2. Corona G, Monami M, Rastrelli G, et al. Type 2 diabetes mellitus and testosterone: A meta-analysis study. Int J Androl. 2011;34: 528-540.
3. van Dam EW, Dekker JM, Lentjes EG, et al. Steroids in adult men with type 1 diabetes: A tendency to hypogonadism. Diabetes Care. 2003;26: 1812-1188.
4. Grossmann M, Thomas MC, Panagiotopoulos S, et al. Low testosterone levels are common and associated with insulin resistance in men with diabetes. J Clin Endocrinol Metab. 2008;93: 1834-1840.
5. Tomar R, Dhindsa S, Chaudhuri A, Mohanty P, Garg R, Dandona P. Contrasting testosterone concentrations in type 1 and type 2 diabetes. Diabetes Care. 2006;29: 1120-1122.
6. Biswas M, Hampton D, Newcombe RG, Rees DA. Total and free testosterone concentrations are strongly influenced by age and central obesity in men with type 1 and type 2 diabetes but correlate weakly with symptoms of androgen deficiency and diabetes-related quality of life. Clin Endocrinol (Oxf). 2012;76: 665-673.
7. Ng Tang Fui M, Hoermann R, Cheung AS, Gianatti EJ, Zajac JD, Grossmann M. Obesity and age as dominant correlates of low testosterone in men irrespective of diabetes status. Andrology. 2013; 1: 906-912.
8. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow- up of the Diabetes Control and Complications Trial cohort. Diabetes Care 1999;22: 99-111.
9. de Boer IH, Rue TC, Cleary PA, et al. Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: An analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort. Arch Intern Med. 2011;171: 412-420.
10. Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care. 1994;17: 1281-1289.
11. Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics. ETDRS report number 7. Ophthalmology 1991;98: 741-756.
12. Bhasin S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in men with androgen deficiency syndromes: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95: 2536-2559.
13. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999;84: 3666-3672.
14. Bhasin S, Pencina M, Jasuja GK, et al. Reference ranges for testosterone in men generated using liquid chromatography tandem mass spectrometry in a community-based sample of healthy nonobese young men in the Framingham Heart Study and applied to three geographically distinct cohorts. J Clin Endocrinol Metab. 2011;96: 2430-2439.
15. Lee DM, Pye SR, Tajar A, et al. Cohort profile: The European Male Ageing Study. Int J Epidemiol. 2013;42: 391-401.
16. Wang C, Jackson G, Jones TH, et al. Low testosterone associated with obesity and the metabolic syndrome contributes to sexual dysfunction and cardiovascular disease risk in men with type 2 diabetes. Diabetes Care. 2011;34: 1669-1675.
17. MacDonald AA, Herbison GP, Showell M, Farquhar CM. The impact of body mass index on semen parameters and reproductive hormones in human males: A systematic review with meta-analysis. Hum Reprod Update. 2010;16: 293-311.
18. Oh JY, Barrett-Connor E, Wedick NM, Wingard DL. Endogenous sex hormones and the development of type 2 diabetes in older men and women: The Rancho Bernardo study. Diabetes Care. 2002;25: 55-60.
19. Haring R, Nauck M, Völzke H, et al. Low serum testosterone is associated with increased mortality in men with stage 3 or greater nephropathy. Am J Nephrol. 2011;33: 209-217.
20. Hammes A, Andreassen TK, Spoelgen R, et al. Role of endocytosis in cellular uptake of sex steroids. Cell. 2005;122: 751-762.
21. Ly LP, Sartorius G, Hull L, et al. Accuracy of calculated free testosterone formulae in men. Clin Endocrinol (Oxf). 2010;73: 382-388.
22. DCCT/EDIC Research Group, de Boer IH, Sun W, et al. Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes. N Engl J Med 2011;365: 2366-2376.